Evidence map›Paper›PMID 23739288›Full record

ArticleLeukemia2013

Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling.

H M Mehta, T Glaubach, A Long, H Lu, B Przychodzen, H Makishima, M A McDevitt, N C P Cross, J Maciejewski, S J Corey

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. GermlineInternational journal of molecular sciences · 2023
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.Clinical cancer research : an official journal of the American Association for Cancer Research · 2016
    Article
  15. G-CSF and GM-CSF in Neutropenia.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

H M MehtaDepartment of Pediatrics (Hematology-Oncology) and Cell and Molecular Biology, Lurie Children's Hospital of Chicago, and the Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
T Glaubach
A Long
H Lu
B Przychodzen
H Makishima
M A McDevitt
N C P Cross
J Maciejewski
S J Corey

Funding

Targeted Therapy of Lyn in Myelodysplastic SyndromeR01CA108922 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI COREY, SETH JOEL · 2006 to 2010
$1.3M
NCI NIH HHS R01 CA108922
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationSignal TransductionHumansLigandsReceptors, Granulocyte Colony-Stimulating FactorLigandsReceptors, Granulocyte Colony-Stimulating Factor

Identifiers

PMID23739288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.